Kaiser says more than 35% of 31,000 striking nurses have returned to work, a figure the union alliance disputes.

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

Academic pressure has become so intense that even preschoolers are taking private extracurricular classes, raising worries ...

Researchers who study caregiving have found that people in the sandwich generation often experience something they call ...

A voluntary program designed to help Medicare Part D beneficiaries manage drug costs could provide considerable benefit to people with cancer, according to study results.The Medicare Prescription Paym ...

Forger takes a more favorable view toward the devices, which he says help keep the overlooked importance of sleep front of ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

TrumpRx, the Trump administration’s much-anticipated direct-to-consumer drug platform, went live on Thursday. However, it ...

Q4 2025 Earnings Call February 6, 2026 9:00 AM ESTCompany ParticipantsJennifer Gilligan - Senior Vice President of ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Scripps Health Medicare Advantage exit ended $75M annual losses and stabilized patient volume, proving financially and operationally sound.

Novo Nordisk is fighting back with CagriSema, a powerful combination therapy that demonstrated 22.7% weight loss in its own Phase 3 trials. While this result is superior to the current market leader, ...